Table of Contents

2019-2024 Global Plasma Protein Therapeutics Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Plasma Protein Therapeutics Consumption 2014-2024
  • 2.1.2 Plasma Protein Therapeutics Consumption CAGR by Region
• 2.2 Plasma Protein Therapeutics Segment by Type
  • 2.2.1 Coagulation Factor
  • 2.2.2 Immune Globulin
  • 2.2.3 Albumin
  • 2.2.4 Other
• 2.3 Plasma Protein Therapeutics Consumption by Type
  • 2.3.1 Global Plasma Protein Therapeutics Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2014-2019)
• 2.4 Plasma Protein Therapeutics Segment by Application
  • 2.4.1 Hemophilia
  • 2.4.2 PID
  • 2.4.3 Other
• 2.5 Plasma Protein Therapeutics Consumption by Application
  • 2.5.1 Global Plasma Protein Therapeutics Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Plasma Protein Therapeutics Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2014-2019)

3 Global Plasma Protein Therapeutics by Players

• 3.1 Global Plasma Protein Therapeutics Sales Market Share by Players
  • 3.1.1 Global Plasma Protein Therapeutics Sales by Players (2017-2019)
  • 3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Players (2017-2019)
• 3.2 Global Plasma Protein Therapeutics Revenue Market Share by Players
  • 3.2.1 Global Plasma Protein Therapeutics Revenue by Players (2017-2019)
  • 3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Players (2017-2019)
• 3.3 Global Plasma Protein Therapeutics Sale Price by Players
• 3.4 Global Plasma Protein Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Plasma Protein Therapeutics Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Plasma Protein Therapeutics Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Plasma Protein Therapeutics by Regions

• 4.1 Plasma Protein Therapeutics by Regions
  • 4.1.1 Global Plasma Protein Therapeutics Consumption by Regions
  • 4.1.2 Global Plasma Protein Therapeutics Value by Regions
• 4.2 Americas Plasma Protein Therapeutics Consumption Growth
• 4.3 APAC Plasma Protein Therapeutics Consumption Growth
• 4.4 Europe Plasma Protein Therapeutics Consumption Growth
• 4.5 Middle East & Africa Plasma Protein Therapeutics Consumption Growth

5 Americas

• 5.1 Americas Plasma Protein Therapeutics Consumption by Countries
  • 5.1.1 Americas Plasma Protein Therapeutics Consumption by Countries (2014-2019)
  • 5.1.2 Americas Plasma Protein Therapeutics Value by Countries (2014-2019)
• 5.2 Americas Plasma Protein Therapeutics Consumption by Type
• 5.3 Americas Plasma Protein Therapeutics Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Plasma Protein Therapeutics Consumption by Countries
  • 6.1.1 APAC Plasma Protein Therapeutics Consumption by Countries (2014-2019)
  • 6.1.2 APAC Plasma Protein Therapeutics Value by Countries (2014-2019)
• 6.2 APAC Plasma Protein Therapeutics Consumption by Type
• 6.3 APAC Plasma Protein Therapeutics Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Plasma Protein Therapeutics by Countries
  • 7.1.1 Europe Plasma Protein Therapeutics Consumption by Countries (2014-2019)
  • 7.1.2 Europe Plasma Protein Therapeutics Value by Countries (2014-2019)
• 7.2 Europe Plasma Protein Therapeutics Consumption by Type
• 7.3 Europe Plasma Protein Therapeutics Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Plasma Protein Therapeutics by Countries
  • 8.1.1 Middle East & Africa Plasma Protein Therapeutics Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Plasma Protein Therapeutics Value by Countries (2014-2019)
• 8.2 Middle East & Africa Plasma Protein Therapeutics Consumption by Type
• 8.3 Middle East & Africa Plasma Protein Therapeutics Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Plasma Protein Therapeutics Distributors
• 10.3 Plasma Protein Therapeutics Customer

11 Global Plasma Protein Therapeutics Market Forecast

• 11.1 Global Plasma Protein Therapeutics Consumption Forecast (2019-2024)
• 11.2 Global Plasma Protein Therapeutics Forecast by Regions
  • 11.2.1 Global Plasma Protein Therapeutics Forecast by Regions (2019-2024)
  • 11.2.2 Global Plasma Protein Therapeutics Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Plasma Protein Therapeutics Forecast by Type
• 11.8 Global Plasma Protein Therapeutics Forecast by Application

12 Key Players Analysis

• 12.1 Shire (Baxalta)
  • 12.1.1 Company Details
  • 12.1.2 Plasma Protein Therapeutics Product Offered
  • 12.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Shire (Baxalta) News
• 12.2 CSL
  • 12.2.1 Company Details
  • 12.2.2 Plasma Protein Therapeutics Product Offered
  • 12.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 CSL News
• 12.3 Grifols
  • 12.3.1 Company Details
  • 12.3.2 Plasma Protein Therapeutics Product Offered
  • 12.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Grifols News
• 12.4 Octapharma
  • 12.4.1 Company Details
  • 12.4.2 Plasma Protein Therapeutics Product Offered
  • 12.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Octapharma News
• 12.5 Kedrion
  • 12.5.1 Company Details
  • 12.5.2 Plasma Protein Therapeutics Product Offered
  • 12.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Kedrion News
• 12.6 LFB Group
  • 12.6.1 Company Details
  • 12.6.2 Plasma Protein Therapeutics Product Offered
  • 12.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 LFB Group News
• 12.7 Biotest
  • 12.7.1 Company Details
  • 12.7.2 Plasma Protein Therapeutics Product Offered
  • 12.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Biotest News
• 12.8 BPL
  • 12.8.1 Company Details
  • 12.8.2 Plasma Protein Therapeutics Product Offered
  • 12.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 BPL News
• 12.9 RAAS
  • 12.9.1 Company Details
  • 12.9.2 Plasma Protein Therapeutics Product Offered
  • 12.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 RAAS News
• 12.10 CBPO
  • 12.10.1 Company Details
  • 12.10.2 Plasma Protein Therapeutics Product Offered
  • 12.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 CBPO News
• 12.11 Hualan Bio
• 12.12 Kamada

13 Research Findings and Conclusion

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Plasma Protein Therapeutics is widely used to treat Hemophilia, PID and Other. The most proportion of Plasma Protein Therapeutics is to treat PID, and the proportion is about 36.1% in 2017.
North America is the largest sales place, with a consumption value market share nearly 37% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 23.7% in 2017. China is an important market of Blood Product in Asia, accounting for 13.4% revenue market share of global market.
Baxter, CSL, Grifols are the leaders of the industry, with 71.6% market share in 2017, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.

According to this study, over the next five years the Plasma Protein Therapeutics market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 31400 million by 2024, from US$ 21300 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Plasma Protein Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Protein Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study considers the Plasma Protein Therapeutics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Coagulation Factor
Immune Globulin
Albumin
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hemophilia
PID
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Plasma Protein Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Plasma Protein Therapeutics market by identifying its various subsegments.
Focuses on the key global Plasma Protein Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma Protein Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Plasma Protein Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.